A Real-world Study to Assess Safety and Effectiveness of Xolair® in Pediatric Chronic Spontaneous Urticaria in China
Clinical trial NCT06053801 · COMPLETED
Trial details
- NCT number
- NCT06053801
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-02-16
- Primary completion
- 2025-08-10
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.